Ascend Capital’s Elanco Animal Health ELAN Stock Holding History

Ascend Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$5.24M	Buy	+150,142	New	+$5.28M	0.26%	98

Other funds holding ELAN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ascend Capital's ELAN Position: Q3 2018 in Review

Ascend Capital opened a new position in Elanco Animal Health (ELAN) in Q3 2018: 150,142 shares worth $5.24M. The stake represents 0.26% of the portfolio and ranks #98 among its holdings.

153 funds tracked by Wall St. Rank hold ELAN as of Q3 2018.

Ascend Capital held 150,142 shares of Elanco Animal Health worth $5.24M as of Q3 2018.
Elanco Animal Health was a new Ascend Capital position in Q3 2018.
Elanco Animal Health made up 0.26% of Ascend Capital's portfolio in Q3 2018, its #98 holding.
153 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.